Evidence map›Paper›PMID 31609002›Full record

ReviewImmunological reviews2019

The five dimensions of B cell tolerance.

Jeffrey L Platt, Mayara Garcia de Mattos Barbosa, Marilia Cascalho

Open access · greenAbstract readReview
In one paragraph

Review in Immunological reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Somatic Cell Fusion in Host Defense and Adaptation.Results and problems in cell differentiation · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jeffrey L PlattDepartment of Surgery, University of Michigan, Ann Arbor, MI, USA.
Mayara Garcia de Mattos BarbosaDepartment of Surgery, University of Michigan, Ann Arbor, MI, USA.
Marilia CascalhoDepartment of Surgery, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · USMichigan Medicine · US

Funding

Hepatocyte xenografts for treatment of acute liver failureR01AI122369 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FOX, IRA J., PLATT, JEFFREY L · 2016 to 2020
$5.0M
Donor-specific B cells in Transplantation.R01AI151588 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASCALHO, MARILIA ISABEL, PLATT, JEFFREY L · 2020 to 2025
$2.7M
Engineering an immuno-isolating hydrogel for restoring ovarian endocrine functionR01EB022033 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIKANOV, ARIELLA · 2016 to 2019
$1.5M
TNRSF13B polymorphisms and the control of innate B cell responses – a double edged swordR21AI159219 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASCALHO, MARILIA ISABEL, PLATT, JEFFREY L · 2021 to 2022
$429k
Enhancing resistance to enteric pathogensR21AI117561 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASCALHO, MARILIA ISABEL, PLATT, JEFFREY L · 2015 to 2016
$426k
NIAID NIH HHS R01 AI122369NIAID NIH HHS R01 AI151588NIAID NIH HHS R21 AI117561NIAID NIH HHS R21 AI159219NIBIB NIH HHS R01 EB022033NIH HHS EB022033NIH HHS R01AI122369
6 · The paper itself

Abstract

B cell tolerance has been generally understood to be an acquired property of the immune system that governs antibody specificity in ways that avoid auto-toxicity. As useful as this understanding has proved, it fails to fully explain the existence of auto-reactive specificities in healthy individuals and contribution these may have to health. Mechanisms underlying B cell tolerance are considered to select a clonal repertoire that generates a collection of antibodies that do not bind self, ie tolerance operates more or less in three dimensions that largely spare autologous cells and antigens. Yet, most B lymphocytes in humans and probably in other vertebrates are auto-reactive and absence of these auto-reactive B cells is associated with disease. We suggest that auto-reactivity can be embodied by extending the concept of tolerance by two further dimensions, one of time and circumstance and one that allows healthy cells to actively resist injury. In this novel concept, macromolecular recognition by the B cell receptor leading to deletion, anergy, receptor editing or B cell activation is extended by taking account of the time of development of normal immune responses (4th dimension) and the accommodation (or tolerance) of normal cells to bound antibody, activation of complement, and interaction with inflammatory cells (fifth dimension). We discuss how these dimensions contribute to understanding B cell biology in health or disease.

Indexed as

AnimalsAntibodiesAutoantigensAutoimmunityB-LymphocytesHumansImmune SystemImmune ToleranceLymphocyte ActivationReceptors, Antigen, B-CellAntibodiesAutoantigensReceptors, Antigen, B-CellABO incompatibilityaccommodationantibodiesB lymphocytestolerance

Identifiers

PMID31609002
PMCPMC10387221
OpenAlexW2981104422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.